Index
Grant: Eradavir — Influenza Treatment RCT (Coefficient Giving → Eradavir)
Verdictconfirmed95%
1 check · 4/9/2026Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Our claim
entire record- Name
- Eradavir — Influenza Treatment RCT
- Amount
- $250,000
- Currency
- USD
- Date
- March 2025
- Notes
[Scientific Research] Open Philanthropy recommended an investment of $250,000 in Eradavir to support a randomized controlled trial of a drug for treating influenza. The team’s novel antiviral approach links two haptens that recruit the immune system to an already approved influen… expand
[Scientific Research] Open Philanthropy recommended an investment of $250,000 in Eradavir to support a randomized controlled trial of a drug for treating influenza. The team’s novel antiviral approach links two haptens that recruit the immune system to an already approved influenza antiviral, zanamivir, which binds to the neuraminidase protein found on the virus and infected cell. This follows our July 2023 investment and falls within our focus area of scientific research.
Source evidence
1 src · 1 checkconfirmed95%deterministic-row-match · 4/9/2026
- Name
- Eradavir — Influenza Treatment RCT
- Grantee
- Eradavir
- Focus Area
- Scientific Research
- Amount
- $250,000.00
- Date
- March 2025
- Description
- Open Philanthropy recommended an investmen
NoteDeterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Case № hRWZFQEQArFiled 4/9/2026Confidence 95%